SPB

Spectrum is a slow-shrinking multi-brand consumer-products company, and the FY2025 numbers confirm it. Revenue fell 5.2% to $2.81B with declines across all three segments — Global Pet Care -6.0% (organic -6.8% on category softness, private-label pressure and tariff-driven e-commerce disruption), Home & Personal Care -6.5% (HPC adjusted-EBITDA margin compressed 120bps to just 4.9%), and Home & Garden -1.0%. Net income dropped 20% to $99.9M, operating income fell 26.8%, and ROE is a thin 5.2%. The MD&A leans heavily on tariffs and inflation as recurring headwinds, not one-offs, and management's own organic-decline figures show the weakness isn't just FX. This is not a growth story; it is a margin-defense story.

What keeps it out of 'sell' territory is capital allocation and price. Operating cash flow actually rose 25% to $204M, leaving roughly $166M of free cash flow against a $2.0B market cap — an ~8% FCF yield. Management is funneling that into an aggressive buyback ($326M repurchased) that cut shares outstanding 16.7% to 23.4M, which is why diluted EPS fell only 5.9% ($3.86) versus the 20% drop in net income. The balance sheet is sound: liabilities/equity of 0.77x, long-term debt nearly flat at $556M, and $2.22B of retained earnings. The stock trades at 0.7x sales — cheap for a branded portfolio — even if 22.1x earnings is full for a business with shrinking top and bottom lines.